🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: vaniprevir (MK7009)

Found 12 matching trials

A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

PHASE2

The study evaluates safety and efficacy of vaniprevir (MK7009), when admini...

Status

Completed

Location

Multiple Locations

Start Date

2009-04-20

Trial ID

NCT00880763

Treatments Being Tested

Vaniprevir Pegylated Interferon (peg-IFN)Ribavirin Comparator: Placebo

Safety and Efficacy of Vaniprevir (MK-7009) With Pegylated Interferon (Peg-IFN) and Ribavirin (RBV) in Treatment-Experienced Hepatitis C Virus (HCV) Participants (MK-7009-009)

PHASE2

The purpose of this study is to test the safety, tolerability, and efficacy...

Status

Completed

Location

Multiple Locations

Start Date

2009-03-27

Trial ID

NCT00704405

Treatments Being Tested

Vaniprevir Pegylated Interferon (Peg-IFN)Ribavirin (RBV)Placebo (PBO)

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

PHASE2

This study will evaluate the safety, tolerability, and efficacy of vaniprev...

Status

Withdrawn

Location

Multiple Locations

Start Date

2010-11

Trial ID

NCT00895882

Treatments Being Tested

vaniprevir (MK7009)Comparator: vaniprevir (MK7009)Comparator: Pegylated Interferon (peg-IFN) alfa-2a Comparator: Ribavirin Comparator: Placebo to vaniprevir

A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)

PHASE1

This was a 3-part study comparing the pharmacokinetics after administration...

Status

Completed

Location

Multiple Locations

Start Date

2009-07-01

Trial ID

NCT01010906

Treatments Being Tested

Vaniprevir 300 mg Vaniprevir 200 mg

Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

PHASE3

The purpose of this study is to evaluate the safety, tolerability, and effi...

Status

Completed

Location

Multiple Locations

Start Date

2011-06-27

Trial ID

NCT01370642

Treatments Being Tested

vaniprevir Placebo to vaniprevir Peg-IFN ribavirin

Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)

PHASE3

The purpose of this study is to evaluate the safety, tolerability, and effi...

Status

Completed

Location

Multiple Locations

Start Date

2011-09-02

Trial ID

NCT01405560

Treatments Being Tested

Vaniprevir peg-IFN ribavirin

Pharmacokinetics of Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Treatment (MK-7009-029)

PHASE1

This study will evaluate the hepatic (liver) and plasma pharmacokinetics of...

Status

Terminated

Location

Multiple Locations

Start Date

2010-01-13

Trial ID

NCT00954993

Treatments Being Tested

Vaniprevir

Evaluating Fine Needle Aspiration to Measure Hepatic Vaniprevir (MK-7009) Concentrations in Participants With Chronic Hepatitis C (MK-7009-048)

PHASE1

This study will evaluate the technical feasibility of using fine needle asp...

Status

Completed

Location

Multiple Locations

Start Date

2012-10-30

Trial ID

NCT01678131

Treatments Being Tested

Vaniprevir 600 mg Peg-IFN alfa-2b Ribavirin Liver samples from FNA Vaniprevir 300 mg Liver samples from CNB

A Study of Vaniprevir (MK-7009) in Participants With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028)

PHASE2

This study will provide vaniprevir 600 mg or 300 mg twice daily in combinat...

Status

Completed

Location

Multiple Locations

Start Date

2009-10-23

Trial ID

NCT00943761

Treatments Being Tested

Vaniprevir 600 mg b.i.d.Vaniprevir 300 mg b.i.d.Pegylated interferon Ribavirin

Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)

PHASE3

The purpose of this study is to evaluate the safety, tolerability, and effi...

Status

Completed

Location

Multiple Locations

Start Date

2011-08-29

Trial ID

NCT01405937

Treatments Being Tested

vaniprevir peg-IFN ribavirin

Previous Next